跳至主要内容
临床试验/NCT06693882
NCT06693882Enrolling By Invitation不适用

Electrical Stimulation of the Optic Nerve in Patients With Glaucoma : Prospective Analysis of Perimetric Data up to 12 Months After Neuromodulatory Treatment.

Glaucoma Center of San Francisco2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
50
试验地点
2
主要终点
Change in visual field mean deviation (MD) from baseline to post-treatment

研究概览

简要总结

The goal of this observational study is to evaluate electrical stimulation of the optic nerve with the Eyetronic Nextwave System device as a possible treatment for glaucoma.

The main question it aims to answer is:

Could this therapy be an option to counteract the loss of visual field seen in glaucoma and thus delay the progression of the disease?

Participants will have approximately 14-18 study visits during 12 months including 10 visits for the electrical stimulation treatment. The treatment involves electrically stimulating the optic nerve by an external approach via the facial skin.

详细描述

  1. During the study visits participants will have: general eye examination (visual acuity check, examination of the front and back of the eye, eye pressure measurement, pupil dilation), Visual field (VF) testing, Imaging the optic nerve with Optical Coherence Tomography (OCT), Optic nerve photos.
  2. The treatment will include ten sessions during 2 weeks on an outpatient basis in a quiet and dimly lit room with the patient comfortably seated or lying down in a reclining chair. Each treatment session will last approximately 60 minutes including the time to determine the treatment settings.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects 18 years or older who have glaucoma
  • Humphrey visual field mean deviation (MD) values between - 6 dB and -20 dB

排除标准

  • Age < 18 years
  • Implanted electronic devices
  • Metallic artifacts in the head (except dentures)
  • Brain tumor
  • Pregnancy
  • Breastfeeding patients
  • Uncontrolled intraocular pressure (IOP)
  • IOP lowering medication started less than six months before enrollment
  • Any intraocular surgery less than 6 months before enrollment
  • Arterial hypertension without appropriate treatment
  • Acute retinal hemorrhage

结局指标

主要结局

Change in visual field mean deviation (MD) from baseline to post-treatment

时间窗: 12 months

Visual field testing will be performed with the Humphrey field analyzer (Carl Zeiss Meditec)

次要结局

  • Change in retinal nerve fiber layer (RNFL) thickness from baseline to post-treatment(12 months)

研究者

发起方
Glaucoma Center of San Francisco
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验